Type of Cancer
Lung
Phase
Division (Location)
Study ID
NCT#
Brief Description
Phase 2, Parallel-Arm Study of MGCD265 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Activating Genetic Alterations in Mesenchymal-Epithelial Transition Factor
To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.